跳至主要内容
临床试验/DRKS00000612
DRKS00000612已完成不适用

An assessment of the potential clinical utility of a new multiplex-PCR assay (VYOO®) in the management of ICU patients with sepsis - KS-2009-028 VYOO-MultiSep

SIRS-Lab GmbH0 个研究点目标入组 1,050 人开始时间: 2011年1月7日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,050

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Signed Informed Consent Form by the patient or their legal representative
  • - All adult (age = 18) patients with suspicion of sepsis, severe sepsis or septic shock (ACCP/SCCM criteria) and indication for blood culture (defined according to Expertengremium Mikrobiologisch-infektiologische Qualitätsstandard” (MiQ 3 a 2007)

排除标准

  • - The additional blood sampling of 10ml (2 x 5 ml) for VYOO® testing is not advisable for medical reasons
  • - Less than two sets of blood cultures could be taken
  • - Absolute neutrophil count is less than 1’500 / µl blood

研究者

发起方
SIRS-Lab GmbH

相似试验